Abstract
Purpose
This study assessed the diagnostic accuracy of C-reactive protein (CRP) after gastroesophageal cancer resection for postoperative inflammatory complications (PIC).
Methods
The clinical data and CRP values of patients operated on for gastroesophageal cancer surgery between 1997 and 2009 were retrospectively analyzed. The results of this study were compared with published data using a meta-analytic approach for diagnostic outcomes.
Results
Of 210 patients included in the study, 59 developed PIC (28.1 %; 95 % CI: 22.5–34.5 %). On the postoperative day (POD) 4 and 7, CRP had the best diagnostic accuracy for PIC (AUC 0.77; 95 % CI, 0.64–0.91, AUC 0.81; 95 % CI, 0.71–0.91). Using a cut-off value of 141 mg/L (95 % CI, 131–278 mg/L) for CRP on POD 4, the sensitivity was 0.78 (95 % CI, 0.55–0.91), the specificity was 0.70 (95 % CI, 0.53–0.83) and the NPV was 0.89 (95 % CI, 0.77–0.95). The in-hospital mortality rate was 3.3 % (95 % CI, 1.5–6.9 %). In a diagnostic meta-analysis that included two additional studies, CRP had a significant predictive value after POD 3.
Conclusion
There is limited evidence for the diagnostic accuracy of CRP levels for PIC after gastroesophageal cancer surgery. CRP levels on POD 4 might be useful to rule out PIC, but its diagnostic accuracy is moderate at best. For clinical routine use CRP levels are clearly not sufficient to predict PIC and have to be interpreted in the context of the whole clinical picture.
Similar content being viewed by others
References
Wang D, Kong Y, Zhong B, Zhou X, Zhou Y (2010) Fast-track surgery improves postoperative recovery in patients with gastric cancer: a randomized comparison with conventional postoperative care. J Gastrointest Surg 14:620–627
Etoh T, Inomata M, Shiraishi N, Kitano S (2010) Revisional surgery after gastrectomy for gastric cancer: review of the literature. Surg Laparosc Endosc Percutan Tech 20:332–337
Farran L, Llop J, Sans M, Kreisler E, Miro M, Galan M, Rafecas A (2008) Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. Dis Esophagus 21:159–164
Rudiger SJ, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353–361
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE (2009) One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care 13:R167
Rivers EP (2010) Point: adherence to early goal-directed therapy: does it really matter? Yes. After a decade, the scientific proof speaks for itself. Chest 138:476–480
Moller MH, Shah K, Bendix J, Jensen AG, Zimmermann-Nielsen E, Adamsen S, Moller AM (2009) Risk factors in patients surgically treated for peptic ulcer perforation. Scand J Gastroenterol 44(145–52):2
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217
Deitmar S, Anthoni C, Palmes D, Haier J, Senninger N, Bruwer M (2009) Are leukocytes and CRP early indicators for anastomotic leakage after esophageal resection? Zentralbl Chir 134:83–89
Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC (2011) Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg 35:1017–1025
Montagnana M, Minicozzi AM, Salvagno GL, Danese E, Cordiano C, De Manzoni G, Guidi GC, Lippi G (2009) Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab 55:187–192
Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA (1990) Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection. Lancet 335:704–707
Naf F, Warschkow R, Kolb W, Zund M, Lange J, Steffen T (2010) Selective decontamination of the gastrointestinal tract in patients undergoing esophageal resection. BMC Surg 10:36
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
DiCiccio TJ, Efron B (1996) Bootstrap confidence intervals. Stat Sci 11:189–212
Janes H, Pepe MS (2008) Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol 168:89–97
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135
Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, Kooistra A, Rau HG, Nibler R, Ludeling S, Unertl K, Ruckdeschel G, Exner H, Schildberg FW (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172–180
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812
Mackay GJ, Molloy RG, O'Dwyer PJ (2011) C-reactive protein as a predictor of postoperative infective complications following elective colorectal resection. Colorectal Dis 13:583–587
Sponholz C, Sakr Y, Reinhart K, Brunkhorst F (2006) Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 10:R145
Ito S, Sato N, Kojika M, Yaegashi Y, Suzuki Y, Suzuki K, Endo S (2005) Serum procalcitonin levels are elevated in esophageal cancer patients with postoperative infectious complications. Eur Surg Res 37:22–28
Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ (2000) Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28:3171–3176
Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210–217
Szczepanik AM, Scislo L, Scully T, Walewska E, Siedlar M, Kolodziejczyk P, Lenart M, Rutkowska M, Galas A, Czupryna A, Kulig J (2011) IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer 14:266–273
Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, Moutardier V, Blache JL (2005) Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94:767–773
Sources of financial support or funding
None.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warschkow, R., Tarantino, I., Ukegjini, K. et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langenbecks Arch Surg 397, 727–736 (2012). https://doi.org/10.1007/s00423-012-0944-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-012-0944-6